CMC Consultants and CMC Gap Analysis: Finding Development Risks Before They Become Delays
Pharmaceutical development generates enormous amounts of technical information. Formulation studies, analytical results, manufacturing data, stability programs, specifications, and process knowledge must eventually form a coherent development story. Missing information or weak technical justification can create problems later in the program. Experienced CMC Consultants can help organizations evaluate this information from a broader development perspective. One particularly valuable tool is a CMC Gap Analysis , which identifies missing, incomplete, or inconsistent elements before they become significant obstacles. What Does a CMC Gap Analysis Examine? A CMC Gap Analysis compares the current state of a development program with the technical and documentation expectations associated with its next stage. The review may cover drug substance, drug product, analytical methods, specifications, manufacturing processes, stability information, control strategies, packaging, and supporti...